An artificial intelligence system for lung cancer screening that has received U.S. FDA 510(k) clearance. The system assists in the detection of nodules from chest CT images to support early cancer detection and improve treatment outcomes.
Manufactured by
Hsinchu, Taiwan
Founded in 2023, V5med is at the forefront of Medical Image AI innovation. Utilizing state-of-the-art AI technology, V5med has forged strategic partnerships with esteemed institutions, including Taipei Veterans General Hospital, National Taiwan University Hospital, and the Taiwan Lung Cancer Society. This collaboration has led to the development of V5 Lung AI , a groundbreaking computer-aided detection (CAD) system for lung cancer screening. V5 Lung AI transforms medical practice by enabling clinicians to detect nodules on low-dose CT (LDCT) images with unparalleled accuracy, thereby significantly reducing examination times . Beyond its efficiency, V5 Lung AI swiftly annotates nodules and provides essential details about their characteristics, such as diameter, volume, nodule type, and lung-RADS score. Remarkably, the system autonomously performs comparative analyses of nodule growth over time, delivering instantaneous assessments of volume doubling time (VDT). Additionally, V5 Lung AI produces detailed reports in accordance with ACR Lung-RADS and Fleischner guidelines following AI analysis. In addition to its pioneering work in lung cancer detection, V5med is committed to advancing technologies for quantifying pulmonary fibrosis, detecting COPD, assessing coronary artery calcification, and diagnosing osteoporosis. V5med's ultimate goal is to establish itself as a global leader in the realm of image AI solutions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Siemens Healthineers Ltd.
China · 1 relevant product
Zhejiang Yizhun Medical AI Technology Co., Ltd.
China · 2 relevant products
Contextvision
China · 3 relevant products
Medical Technology for Trading (Canon)
Japan · 1 relevant product
Remidio Innovative Solutions Pvt. Ltd.
India · 1 relevant product
Feipu Intelligent Technology (Shanghai) Co., Ltd.
China · 2 relevant products
Infervision
China · 3 relevant products
Suzhou Ruiqian Technologies Co., Ltd
China · 1 relevant product
Hangzhou Precision MedCare co.LTD
China · 2 relevant products
Guangzhou LBP Medicine Science & Technology Co.,Ltd.
China · 2 relevant products
34 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 58 closest product alternatives
Siemens Healthineers Ltd. · China
AI-powered software for automated lung nodule detection and classification in CT imaging. Assists clinicians in early lung cancer identification and risk assessment.
Zhejiang Yizhun Medical AI Technology Co., Ltd. · China
A clinical AI solution specifically designed for breast cancer screening and diagnosis utilizing advanced artificial intelligence algorithms. This integrated solution assists healthcare providers in detecting and diagnosing breast cancer with improved accuracy.
Contextvision · China
AI-driven ultrasound analysis software designed for breast cancer detection and screening applications. Delivers enhanced diagnostic insights at the point-of-care with improved clinical accuracy.
Medical Technology for Trading (Canon) · Japan
Specialized clinical solutions for lung cancer detection and screening programs.
Remidio Innovative Solutions Pvt. Ltd. · India
AI-powered screening system for diabetic retinopathy detection using fundus imaging. Enables non-invasive, population-scale vision screening in primary care and community settings to identify patients requiring specialist referral. Combines portable fundus photography with machine learning algorithms for early disease detection and risk stratification.
Feipu Intelligent Technology (Shanghai) Co., Ltd. · China
AI-powered non-invasive health screening system that integrates multimodal optical imaging with computational biology models to assess multiple health parameters including glucose, blood pressure, and body composition from facial analysis. Combines digital biomarkers with machine learning algorithms for real-time multi-dimensional health predictions across clinical and consumer health settings.
Contextvision · China
Ultrasound-based diagnostic software for thyroid nodule assessment and screening. Utilizes AI technology to improve diagnostic confidence in thyroid pathology detection.
Infervision · China
AI-powered diagnostic platform utilizing deep learning and convolutional neural networks to assist clinicians in detecting and analyzing diseases across multiple organ systems including lungs, cardiovascular, breast, and skeletal structures. Integrates medical imaging analysis with clinical workflow support for disease screening, diagnosis, and treatment planning across oncology, infectious disease, and cardiovascular applications.
Suzhou Ruiqian Technologies Co., Ltd · China
AI-assisted diagnostic system for cervical cellular carcinoma detection and screening. Analyzes cytological samples to support pathologist interpretation and improve diagnostic accuracy in cervical cancer screening programs.
Hangzhou Precision MedCare co.LTD · China
AI-powered breast ultrasound image management and analysis software utilizing deep learning algorithms for rapid breast cancer screening and tumor characterization. The system assists clinicians in detecting and differentiating benign and malignant lesions with enhanced diagnostic accuracy and workflow efficiency.
Guangzhou LBP Medicine Science & Technology Co.,Ltd. · China
An AI-powered system for automated analysis of cervical cytology specimens compatible with both membrane and sedimentation preparation methods. This system represents digital pathology advancement in cervical cancer screening.
Beijing Healtech Pharmaceutical Technology Co.,Ltd · China
Artificial intelligence-based diagnostic software for analyzing cervical cell digital pathology images to support cervical cancer screening. The system assists pathologists in accurate identification and classification of cellular abnormalities.
46 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products